Imigliptin Dihydrochloride is a selective dipeptidyl peptidase IV (DPP-4) inhibitor potentially for the treatment of type II diabetes. References: Liu D, Ma X, Liu Y, Zhou H, Shi C, Wu F, Jiang J, Hu P. Quantitative prediction of human pharmacokinetics and pharmacodynamics of imigliptin, a novel DPP-4 inhibitor, using allometric scaling, IVIVE and PK/PD modeling methods. Eur J Pharm Sci. 2016 Jun 30;89:73-82. doi: 10.1016/j.ejps.2016.04.020. Epub 2016 Apr 21. PubMed PMID: 27108678.

纯度：≥98%

CAS：1314944-07-4